Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05069883

Enrollment

180

Registered

2021-10-06

Start date

2018-01-01

Completion date

2021-03-31

Last updated

2021-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrence

Brief summary

It was a randomized controlled trial conducted at department of Urology, Armed Forces Institute of Urology, Rawalpindi from 1st January, 2018 July 2019 to 31st March 2021 to determine the role of oral steroids after Direct Vision Internal Urethrotomy to reduce the recurrence rate of urethral strictures.

Interventions

DRUGNo steroid

In this group no Oral steroid medication (palcebo medication) after Direct Vision Internal Urethrotomy

DRUGSteroid Drug

In this group Oral steroid medication after Direct Vision Internal Urethrotomy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

MALE

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Patients with urethral stricture with restricted urine flow of \< 15 ml/min on uroflowmetry

Exclusion criteria

* Patients presenting with post-anastomotic urethroplasty strictures (assessed on history and medical record), * Patients with post-TURP strictures * Patients with neurogenic bladder * Patients with prior history of steroid use * Patients with extravasation during optical internal urethrotomy

Design outcomes

Primary

Measure	Time frame	Description
Recurrence of Urethral Stricture	6 months post-operatively	Number of patients presenting with recurrence of urethral stricture after direct vision internal urethrotomy

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026